Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Canadian Medical Association Journal
Pharmacology of crystal meth
July 5th, 2008
When smoked, crystal meth rapidly achieves high concentrations in the brain without the burdens of the intravenous route. Kish reviews the actions of methamphetamine and explains the potential role of dopamine in methamphetamine craving. The author states that there is no medication approved for the treatment of relapses of methamphetamine addiction, but potential therapeutic agents targeted to dopamine and non-dopamine systems are in clinical testing. "Research into the pharmacologic treatment of methamphetamine addiction has largely been limited to studies in animals," states Kish. "Although animal studies are essential to the development of new...
Source: Law & Health Weekly (2008-07-05)
|
